Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.

MLA

Lin, Yu-Li, et al. “Fibroblast-Stimulating Lipopeptide-1 as a Potential Mucosal Adjuvant Enhances Mucosal and Systemic Immune Responses to Enterovirus 71 Vaccine.” Vaccine, vol. 36, no. 29, July 2018, pp. 4331–38. EBSCOhost, https://doi.org/10.1016/j.vaccine.2018.05.090.

APA

Lin, Y.-L., Cheng, P.-Y., Chin, C.-L., Huang, L.-M., Lin, S.-Y., & Chiang, B.-L. (2018). Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine. Vaccine, 36(29), 4331–4338. https://doi.org/10.1016/j.vaccine.2018.05.090

Chicago

Lin, Yu-Li, Pei-Yun Cheng, Chiao-Li Chin, Li-Min Huang, Shr-Yu Lin, and Bor-Luen Chiang. 2018. “Fibroblast-Stimulating Lipopeptide-1 as a Potential Mucosal Adjuvant Enhances Mucosal and Systemic Immune Responses to Enterovirus 71 Vaccine.” Vaccine 36 (29): 4331–38. doi:10.1016/j.vaccine.2018.05.090.